Can We Deal with Learning Curves in Acute Stroke?

When an interventional cardiology center, where interventional cardiology specialists work alongside neurologists and radiologists, start a thrombectomy program in acute stroke, results achieved are similar to those at an interventional neurology center.

¿Podemos afrontar la curva de aprendizaje en el stroke agudo?

Mechanical thrombectomy has proven to be the best treatment option for acute ischemic stroke. However, it is not widely available, mainly due to logistic difficulties.

An endovascular treatment program for acute stroke was initiated in 2012 at a cardiac cath lab.

The decision to perform the procedure was taken by neurologists based on symptoms and tomographic findings. The primary endpoint was functional result (Modified Rankin Scale score) of patients 3 months after the procedure.

From the beginning of the program in 2012 until the end of enrollment in 2019, 333 patients were treated.

Clinical results did not change significantly during this period of time and almost half the population achieved a modified Rankin Scale score of 0-2 (47.9%).

Symptomatic intracerebral hemorrhage was observed in 5.7% of patients, while embolization of new vascular territory was informed in 1.8%.


Read also: Experts Reach Consensus on Post TAVR Pacemaker Indication.


The clinical results were as desired from the beginning of the program without the effect of a learning curve.

These data support the potential for interventional cardiologists to treat acute stroke in regions where therapy is not available due to a lack of interventional neurologists.

Conclusion

An interventional cardiology center with experienced staff working as a team with neurologists and radiologists can begin an endovascular treatment program for acute stroke with results comparable to those of a center with interventional neurologists. These results can be obtained from the start without a learning curve.

Original Title: Stable Clinical Outcomes When a Stroke Thrombectomy Program Is Started in an Experienced Cardiology Cath Lab.

Reference: Jakub Sulženko et al. JACC Cardiovasc Interv. 2021 Apr 12;14(7):785-792. doi: 10.1016/j.jcin.2021.01.025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....